Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status

Overview of attention for article published in Investigational New Drugs, July 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,196 followers.

Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status. https://t.co/s2yoDb2svX

RT @cody_lo: My new paper - copper complexes as a Tx option for #cancer instead of platinum drugs https://t.co/RDymtSmQu2 #medicine #academ…

My new paper - copper complexes as a Tx option for #cancer instead of platinum drugs https://t.co/RDymtSmQu2 #medicine #academia #research https://t.co/NWNt85vSZd

Platinum resistant #ovariancancer is significant clinical problem. This https://t.co/aXGbItJB5e examines copper complexes as alternatives